Humacyte (NASDAQ:HUMA) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-13. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Humacyte will report an earnings per share (EPS) of $-0.21.

The market awaits Humacyte's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Historical Earnings Performance

In the previous earnings release, the company beat EPS by $0.09, leading to a 0.0% drop in the share price the following trading session.

Here's a look at Humacyte's past performance and the resulting price change:

Market Performance of Humacyte's Stock

Shares of Humacyte were trading at $1.19 as of May 09. Over the last 52-week period, shares are down 79.52%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Humacyte visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.